Aurinia Pharmaceuticals (AUP) News Today → Trump’s Former Wingman Bets Big on AI (From Banyan Hill Publishing) (Ad) Free AUP Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 3, 2024 | msn.comAurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2024 Earnings Call TranscriptMay 3, 2024 | seekingalpha.comAurinia Pharma: A Welcome Change To The Thesis (Rating Upgrade)May 2, 2024 | msn.comAUPH Stock Earnings: Aurinia Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024May 2, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: BridgeBio Pharma (BBIO), Aurinia Pharmaceuticals (AUPH) and 908 Devices (MASS)May 2, 2024 | washingtonpost.comAurinia: Q1 Earnings SnapshotFebruary 29, 2024 | barrons.comAurinia Pharmaceuticals Inc.February 15, 2024 | msn.comAurinia Pharmaceuticals Finds No Buyer After Strategic Business Review, Launches Stock BuybackFebruary 15, 2024 | msn.comExclusive-Kidney drug developer Aurinia fails to clinch a sale, sources sayFebruary 15, 2024 | msn.comAurinia Pharma GAAP EPS of -$0.19 misses by $0.03, revenue of $45.1M misses by $0.06MFebruary 15, 2024 | msn.comAurinia drops after Q4 miss; strategic review failsFebruary 15, 2024 | reuters.comAurinia to stop development of immunotherapies after strategic reviewFebruary 15, 2024 | reuters.comExclusive: Kidney drug developer Aurinia fails to clinch a sale, sources sayFebruary 14, 2024 | msn.comAurinia Pharma Q4 2023 Earnings PreviewFebruary 8, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA) and Arrowhead Pharmaceuticals (ARWR)February 8, 2024 | msn.comAurinia Pharmaceuticals (AUPH) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 ReleaseNovember 13, 2023 | benzinga.comAurinia Pharmaceuticals Announces Collaboration Partner Otsuka Filed New Drug Application (NDA) for LUPKYNIS® (Voclosporin) in JapanNovember 13, 2023 | markets.businessinsider.comAurinia Says Its Partner Otsuka Filed NDA For Voclosporin In JapanNovember 6, 2023 | markets.businessinsider.comStrong 3Q Performance and Growing Lupkynis Sales Bolster Aurinia Pharmaceuticals’ Buy Rating: An In-depth Analysis by David Martin, PhDNovember 2, 2023 | seekingalpha.comAurinia Pharmaceuticals Inc. (AUPH) Q3 2023 Earnings Call TranscriptSeptember 27, 2023 | msn.comAurinia Pharmaceuticals: Reassessing As It Gains TractionAugust 3, 2023 | seekingalpha.comAurinia Pharmaceuticals Inc. (AUPH) Q2 2023 Earnings Call TranscriptJuly 18, 2023 | msn.comAurinia Pharmaceuticals Stock Returns To A Rising Relative StrengthJune 29, 2023 | benzinga.comAurinia Board of Directors Announces Exploration of Strategic Alternatives to Maximize Shareholder ValueJune 16, 2023 | msn.comAurinia Pharmaceuticals: Still In The Game With Lupkynis SalesMay 18, 2023 | msn.comAurinia Pharmaceuticals Earnings Perspective: Return On Capital EmployedMay 17, 2023 | technews.tmcnet.comMKT Capital Thanks Fellow Shareholders for Their Strong Support at Aurinia's 2023 Annual MeetingMay 9, 2023 | finance.yahoo.comNews Flash: Analysts Just Made A Sizeable Upgrade To Their Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) ForecastsMay 6, 2023 | markets.businessinsider.comBloom Burton Remains a Buy on Aurinia Pharmaceuticals (AUPH)May 5, 2023 | technews.tmcnet.comMKT Capital Issues Statement Regarding Aurinia's Disappointing First Quarter 2023 Financial ResultsMay 4, 2023 | finance.yahoo.comAurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational ResultsMay 4, 2023 | msn.comAurinia Pharma gains after Q1 beat and guidance raiseMay 4, 2023 | msn.comAurinia Pharmaceuticals: Q1 Earnings InsightsMay 3, 2023 | theglobeandmail.comISS Recommends Aurinia Shareholders Vote Against the Company’s Named Executive Officers’ CompensationApril 25, 2023 | finance.yahoo.comToni Braxton and Aurinia Want People with Lupus Nephritis to Get Uncomfortable to Protect their KidneysApril 25, 2023 | marketwatch.comMKT Capital Issues Letter to Aurinia Shareholders Announcing its Intention to Withhold Support for Three Directors at 2023 Annual MeetingApril 11, 2023 | msn.comWhy Aurinia Pharmaceuticals Stock Is Glowing Green TodayApril 4, 2023 | finance.yahoo.comWe Think Aurinia Pharmaceuticals (NASDAQ:AUPH) Can Easily Afford To Drive Business GrowthMarch 9, 2023 | insidermonkey.comAurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2022 Earnings Call TranscriptFebruary 21, 2023 | msn.comAurinia Pharmaceuticals (AUPH) Expected to Beat Earnings Estimates: Should You Buy?January 25, 2023 | yahoo.comAurinia Announces PTAB Has Terminated Inter Partes ReviewJanuary 25, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Taro Pharmaceutical (TARO) and Aurinia Pharmaceuticals (AUPH)January 25, 2023 | msn.comAurinia adds 11% amid patent wins in the U.S. and EUJanuary 16, 2023 | nz.finance.yahoo.comInvestors ignore increasing losses at Aurinia Pharmaceuticals (NASDAQ:AUPH) as stock jumps 21% this past weekJanuary 6, 2023 | benzinga.comAurinia Provides Preliminary Unaudited Fourth Quarter and Full-year 2022 Net Revenue ResultsJanuary 5, 2023 | seekingalpha.comAurinia's Patent Dispute Is Over, But Without A Buyout, There's No UpsideJanuary 4, 2023 | msn.comAurinia Pharmaceuticals gains amid M&A speculation following patent settlementJanuary 4, 2023 | nasdaq.comAurinia (AUPH) Soars 37.5%: Is Further Upside Left in the Stock?January 3, 2023 | marketwatch.comAurinia Pharma Shares Rise 37% After Patent Settlement With Sun PharmaNovember 30, 2022 | finance.yahoo.comAurinia Announces the Great Britain Marketing Authorization of LUPKYNIS® (voclosporin) for the Treatment of Lupus NephritisNovember 3, 2022 | seekingalpha.comAurinia Pharmaceuticals Inc. (AUPH) Q3 2022 Earnings Call Transcript Get Aurinia Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AUP and its competitors with MarketBeat's FREE daily newsletter. Email Address Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide AUP Media Mentions By Week AUP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AUP News Sentiment▼0.000.51▲Average Computer and Technology News Sentiment AUP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AUP Articles This Week▼00▲AUP Articles Average Week Get Aurinia Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AUP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Docebo News Enghouse Systems News Nuvei News Lightspeed Commerce News TELUS International (Cda) News Converge Technology Solutions News Softchoice News Evertz Technologies News Hammond Power Solutions News Dye & Durham News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:AUP) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTrump Asset Seizure Threat Alert: Could Your Savings Be Next?American Hartford Gold GroupDoes this make you sick?Allegiance GoldHow to Make 100X on the AI BoomInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Monetary GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurinia Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
